Patents-Review.com
🔗 Permalink
Assignee profile:

ESTETRA SRL

City:

Liège

Country:

Belgium

Published Applications:

20

Last publication date:

2026-04-16

Patent Grants:

10

Last grant date:

2025-09-30

Top Inventors for applications by ESTETRA SRL

These are the the leading inventors for applications assigned to ESTETRA SRL:

Recent patent applications by ESTETRA SRL

ESTETRA SRL based in Liège, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-04-16
US20260102408A1
Human necessities

CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS

 #2 | 2026-04-02
US20260090995A1
Human necessities

ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT

 #3 | 2026-02-05
US20260034147A1
Human necessities

COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS

 #4 | 2025-11-27
US20250360147A1
Human necessities

METHODS USING COMBINED ORAL CONTRACEPTIVE COMPOSITIONS WITH REDUCED CARDIOVASCULAR EFFECTS

 #5 | 2025-10-23
US20250325467A1
Human necessities

COMPOSITIONS FOR PREVENTING OR TREATING SKIN AGING

 #6 | 2025-10-09
US20250313592A1
Chemistry; metallurgy

PROCESS FOR THE PRODUCTION OF ESTETROL INTERMEDIATES

 #7 | 2025-05-15
US20250152608A1
Human necessities

CONTRACEPTIVE METHODS WITH IMPROVED PEARL INDEX

 #8 | 2025-05-15
US20250152604A1
Human necessities

CONTRACEPTIVE METHODS WITH SCHEDULED BLEEDING EFFECTS

 #9 | 2025-03-27
US20250099485A1
Human necessities

COMPOSITIONS FOR PROMOTING HAIR GROWTH

 #10 | 2024-07-18 ✅ Patent 12,427,114 granted on 2025-09-30
US20240238209A1
Human necessities

ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT

 #11 | 2023-09-21 ✅ Patent 11,793,760 granted on 2023-10-24
US20230293442A1
Human necessities

Orodispersible dosage unit containing an estetrol component

 #12 | 2023-08-10 ✅ Patent 12,233,074 granted on 2025-02-25
US20230248743A1
Human necessities

Contraceptive methods with improved pearl index

 #13 | 2023-03-09 ✅ Patent 12,458,651 granted on 2025-11-04
US20230073911A1
Human necessities

COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS

 #14 | 2023-02-16 ✅ Patent 11,666,585 granted on 2023-06-06
US20230050253A1
Human necessities

Compounds and their uses for alleviating menopause-associated symptoms

 #15 | 2023-02-09 ✅ Patent 11,896,602 granted on 2024-02-13
US20230041304A1
Human necessities

Method for preventing pregnancy

 #16 | 2023-02-02 ✅ Patent 12,390,478 granted on 2025-08-19
US20230031329A1
Human necessities

COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS

 #17 | 2023-01-26
US20230025785A1
Human necessities

COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS

 #18 | 2022-07-07 ✅ Patent 12,458,649 granted on 2025-11-04
US20220211722A1
Human necessities

CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS

 #19 | 2022-03-31 ✅ Patent 11,964,055 granted on 2024-04-23
US20220096385A1
Human necessities

Orodispersible dosage unit containing an estetrol component

 #20 | 2020-11-12 ✅ Patent 11,957,694 granted on 2024-04-16
US20200352959A1
Human necessities

Orodispersible dosage unit containing an estetrol component

Also check out ESTETRA SRL's (Liege, Belgium) applicant profile with 19 patent applications submitted.

AssigneeID:

325669 ⎘